The Pharma industry is up 1.4% in the last week, with Eli Lilly up 3.4%. This means that the industry has gained 15% over the past year. Earnings are forecast to grow by 24% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 17 Aug 2024 | US$2.0t | US$362.1b | US$21.8b | 17.3x | 92.2x | 5.6x |
Mon, 15 Jul 2024 | US$2.0t | US$357.7b | US$13.8b | 15.9x | 146.2x | 5.7x |
Wed, 12 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.9x | 137.9x | 5.4x |
Fri, 10 May 2024 | US$1.9t | US$358.2b | US$13.5b | 20.4x | 137.8x | 5.2x |
Sun, 07 Apr 2024 | US$1.9t | US$355.2b | US$22.8b | 24.7x | 82.2x | 5.3x |
Tue, 05 Mar 2024 | US$1.9t | US$355.3b | US$22.5b | 24.1x | 84.5x | 5.3x |
Thu, 01 Feb 2024 | US$1.8t | US$351.7b | US$24.9b | 28.7x | 71x | 5x |
Sat, 30 Dec 2023 | US$1.7t | US$375.2b | US$33.8b | 31.9x | 49.9x | 4.5x |
Mon, 27 Nov 2023 | US$1.7t | US$375.1b | US$33.9b | 26.2x | 48.8x | 4.4x |
Wed, 25 Oct 2023 | US$1.6t | US$382.7b | US$44.7b | 14.7x | 36.7x | 4.3x |
Fri, 22 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 18.9x | 38.4x | 4.4x |
Sun, 20 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 18.5x | 40.4x | 4.7x |
Tue, 18 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 18.2x | 27.7x | 4.2x |
Thu, 15 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.9x | 28.7x | 4.4x |
Sat, 13 May 2023 | US$1.7t | US$392.8b | US$60.4b | 20.4x | 28.7x | 4.4x |
Mon, 10 Apr 2023 | US$1.7t | US$401.3b | US$69.7b | 16.9x | 23.7x | 4.1x |
Wed, 08 Mar 2023 | US$1.6t | US$401.0b | US$69.4b | 16.8x | 22.4x | 3.9x |
Fri, 03 Feb 2023 | US$1.7t | US$403.0b | US$70.8b | 17.8x | 23.4x | 4.1x |
Sun, 01 Jan 2023 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.3x |
Tue, 29 Nov 2022 | US$1.8t | US$403.7b | US$70.7b | 16.4x | 24.8x | 4.3x |
Thu, 27 Oct 2022 | US$1.7t | US$403.0b | US$72.1b | 13.6x | 23.2x | 4.1x |
Sat, 24 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 12.8x | 21.9x | 3.9x |
Mon, 22 Aug 2022 | US$1.7t | US$402.8b | US$70.1b | 15.3x | 23.7x | 4.1x |
Wed, 20 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22x | 26.1x | 4.3x |
Fri, 17 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20x | 24.1x | 4x |
Sun, 15 May 2022 | US$1.6t | US$392.5b | US$64.4b | 20.4x | 25.3x | 4.2x |
Tue, 12 Apr 2022 | US$1.7t | US$373.8b | US$60.7b | 22.5x | 28x | 4.6x |
Thu, 10 Mar 2022 | US$1.6t | US$373.6b | US$60.2b | 19.9x | 25.9x | 4.2x |
Sat, 05 Feb 2022 | US$1.6t | US$365.5b | US$52.7b | 21.1x | 30x | 4.3x |
Mon, 03 Jan 2022 | US$1.7t | US$361.1b | US$37.8b | 22.9x | 44x | 4.6x |
Wed, 01 Dec 2021 | US$1.5t | US$361.1b | US$38.1b | 22.6x | 40.2x | 4.2x |
Fri, 29 Oct 2021 | US$1.5t | US$340.9b | US$29.4b | 19.6x | 52x | 4.5x |
Sun, 26 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 22x | 58.3x | 4.5x |
Tue, 24 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.7x | 62.2x | 4.7x |
62.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 3.87% | |
Healthcare | 2.09% | |
Pharma | 1.39% | |
Pharma | 1.39% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$922.12 | 3.4% +US$27.4b | 68.8% | PE113.1x | |
BMY Bristol-Myers Squibb | US$49.36 | 5.7% +US$5.4b | -20.5% | PS2.2x | |
TEVA Teva Pharmaceutical Industries | US$18.26 | 4.8% +US$940.4m | 91.0% | PS1.3x | |
ELAN Elanco Animal Health | US$14.49 | 11.1% +US$716.8m | 24.7% | PS1.6x | |
RPRX Royalty Pharma | US$27.17 | 3.5% +US$407.8m | -7.4% | PE18.1x |